Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

342
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
342
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

325
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
325
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

1.3K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

850
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
850
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

307
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
307
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

440
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
440

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Off-Label Dapagliflozin After Atrial Fibrillation Ablation: A Reasonable Intervention or Overstretching the Evidence?

Circulation·2026
Same author

AI-based multiomics profiling reveals complementary omics contributions to personalized prediction of cardiovascular disease.

Nature communications·2026
Same author

Gut Microbiota and Stroke: New Insights into the Gut-Brain-Vascular Axis.

Current atherosclerosis reports·2026
Same author

Update on left atrial appendage closure for neurologists.

European stroke journal·2026
Same author

Non-antiarrhythmic pharmacotherapy in cardio-renal-metabolic disease and incident atrial fibrillation: a trial meta-analysis.

European heart journal·2026
Same author

Long-Term Follow-Up After Atrioventricular Node Ablation in Patients With Atrial Fibrillation: A Nationwide Danish Cohort Study.

Journal of cardiovascular electrophysiology·2026

Related Experiment Video

Updated: Jan 9, 2026

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.9K

The Coronary Microcirculation Re-explored: Pathophysiological Insights and Clinical Implications.

Ahmed Elamin1, Mustafa Abdimalik2, Mohanad Abdelrahim1

  • 1Department of Cardiology, Liverpool University Hospitals NHS Foundation Trust Liverpool, UK.

European Cardiology
|December 5, 2025
PubMed
Summary

Coronary microvascular dysfunction (CMD) causes myocardial ischaemia, especially in patients without blocked arteries. Understanding CMD

Keywords:
Coronary microvascular dysfunctiondiagnostic imagingendothelial dysfunctionendothelin-1myocardial ischaemiapharmacotherapy

More Related Videos

Dynamic Measurement and Imaging of Capillaries, Arterioles, and Pericytes in Mouse Heart
07:16

Dynamic Measurement and Imaging of Capillaries, Arterioles, and Pericytes in Mouse Heart

Published on: July 29, 2020

6.0K
Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
08:35

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

3.0K

Related Experiment Videos

Last Updated: Jan 9, 2026

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.9K
Dynamic Measurement and Imaging of Capillaries, Arterioles, and Pericytes in Mouse Heart
07:16

Dynamic Measurement and Imaging of Capillaries, Arterioles, and Pericytes in Mouse Heart

Published on: July 29, 2020

6.0K
Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
08:35

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

3.0K

Area of Science:

  • Cardiology
  • Vascular Biology
  • Physiology

Background:

  • Coronary microvascular dysfunction (CMD) is a key cause of myocardial ischaemia.
  • It significantly affects patients without obstructive coronary artery disease.

Purpose of the Study:

  • To review the anatomy and physiology of coronary microcirculation.
  • To explore the role of endothelial dysfunction and endothelin-1 in CMD.
  • To discuss diagnostic and therapeutic strategies for CMD.

Main Methods:

  • Review of existing literature on coronary microcirculation.
  • Emphasis on endothelial dysfunction and endothelin-1.
  • Discussion of diagnostic tools like PET, cardiac MRI, and intracoronary testing.

Main Results:

  • Endothelial dysfunction and endothelin-1 are central to CMD pathogenesis.
  • Various invasive and non-invasive methods aid CMD diagnosis.
  • Risk factor modification and pharmacotherapy are current management mainstays.

Conclusions:

  • A thorough grasp of CMD is vital for accurate diagnosis.
  • Developing effective treatments for ischaemic symptoms without coronary obstruction is crucial.
  • Targeting endothelin pathways presents a promising therapeutic avenue.